insights_auto
Zakaj je tečaj NOTA padel 2,78%?
Podrobneje raziščichevron_right
NOTA:FRA
Novartis
140,00 €
arrow_downward
−2,78%(−4,00) 1D
19. nov., 08:01:04 GMT +1 · EUR
search
Vsi simboli
| Simbol | Cena | Sprememba | Odstotna sprememba |
|---|
insights_autoGeneriranje najpomembnejših vpogledov za NOTA …
Odpri
140,00 €
Visoka
140,00 €
Nizka
140,00 €
Tržna kapitalizacija
261,30 mrd.
Povprečni promet
8,00
Promet
0,00
52-tedenski najvišji tečaj
146,00 €
52-tedenski najnižji tečaj
105,50 €
Št. zaposlenih
75 tis.
Odpri
140,00 €
Visoka
140,00 €
Nizka
140,00 €
Tržna kapitalizacija
261,30 mrd.
Povprečni promet
8,00
Promet
0,00
52-tedenski najvišji tečaj
146,00 €
52-tedenski najnižji tečaj
105,50 €
Št. zaposlenih
75 tis.
Novice
Iz spletnih virov in novičarskih partnerjev
Yahoo Finance
·
pred 2 urama
Novartis forecasts 5% annual sales growth through 2031
Investing.com Nigeria
·
pred 3 urami
Novartis forecasts 5% annual sales growth through 2031 By Investing.com
WSJ
·
pred 3 urami
Novartis Sees Sales Growth Through 2031
Euronext Markets: Real-time Stock Market Data | live
·
pred 3 urami
Novartis targets 5% annual sales growth through 2031
Profil
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Vizitka: Novartis
Generalni direktorVasant Narasimhan
Št. zaposlenih75,3 tis.
Ustanovljeno7. mar. 1996
SedežBasel, Basel, Švica
SektorHealth Care
Panoga-
Spletno mestonovartis.com